Purchase Order 75N92E20P00085

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order contract to the Center For Bioethics And Research, Nigeria (doing business as West African Bioethics Training Program), a non-profit organization. The $443,700.00 contract is to enroll and collect samples from subjects in Nigeria with type 2 diabetes (T2D) and subjects with T2D who carry the sickle cell trait. The one-year contract, which...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $21.5 million delivery order contract to the University of Alabama at Birmingham (UAB) on July 1, 2023, to serve as the Coordinating Center for the CARDIA (Coronary Artery Risk Development in Young Adults) Study through June 30, 2033. This cost-no-fee delivery order supports a longitudinal epidemiological research initiative that began in 1985-1986 to assess the evolution of coronary artery disease risk factors in initially...

This is a sole-source firm-fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Prevention Genetics LLC, a for-profit limited liability company, to provide specialized genetic testing services. The contract, valued at $60,000.00, is for the continuation of genetic analysis of the TNXB and CAH-X genes to support the NIH's ongoing Natural History Study of Patients with Excess Androgens, protocol #06-CH-0011. Prevention Genetics is the only CLIA-certified...

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to the Nigerian Institute Of Medical Research, a non-profit research organization, for the recruitment and clinical evaluation of participants for a Chronic Kidney Disease project in Hadejia, Jigawa State, Nigeria. The contract has a potential value of $194,832.00 and a completion date of September 18, 2020. The award...

The National Heart, Lung, and Blood Institute of the National Institutes of Health within the Department of Health and Human Services awarded a $391,500 purchase order to The Broad Institute, Inc. for whole genome sequencing services related to sickle cell disease. Per the pre-solicitation notice, the Broad Institute will sequence the DNA of 5,000 sickle cell patients to identify genetic factors influencing clinical outcomes. Performance will occur in Cambridge, Massachusetts over a 24-month...

Prevention Genetics LLC was awarded a one-year, firm fixed price purchase order valued at fifty thousand dollars by the National Institutes of Health Clinical Center of the Department of Health and Human Services. Under this contract, Prevention Genetics will provide unspecified services to NIH Clinical Center at its place of performance in Bethesda, Maryland, to support the agency's biomedical research mission. No major subcontractors or set aside designations were identified. The award...

The National Heart, Lung, and Blood Institute awarded a delivery order valued at $1.25 million to the University of Alabama at Birmingham (UAB) to serve as the coordinating center for the Coronary Artery Risk Development in Young Adults (CARDIA) Study. This delivery order, issued on March 13, 2026, represents a cost-no-fee arrangement with an ultimate completion date of January 31, 2027. The work will be performed in Birmingham, Alabama. As the coordinating center, UAB will provide...

The federal contract award HHSN269201600343P was issued by the National Institutes of Health (NIH) Clinical Center to Preventiongenetics LLC, a for-profit limited liability company that specializes in genetic testing services. The $8,000 firm fixed-price purchase order is for specialized genetic testing and analysis to support ongoing research studies at the NIH Clinical Center. Preventiongenetics LLC, doing business as Prevention Genetics, has established itself as a trusted provider of genetic...

<p>The Centers for Disease Control and Prevention (CDC) awarded a $520,661 definitive contract to Rprd Diagnostics, LLC Rprdx Division to conduct a Pharmacogenetic Allele Frequencies Study. The prime contractor will perform the study in Milwaukee, Wisconsin from September 1, 2023 through August 31, 2025. The contract utilizes a time and materials pricing structure. No subcontractors were identified.</p>

The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for...